Dr. Karin Hehenberger, is the CEO and Co-Founder of Lyfebulb, an organization whose mission is to "Reduce the burden of chronic disease through the power of the patient."

In our conversation we discussed:

• The origin and goals of Lyfebulb since its inception in 2014.
• How her own diagnosis with Type 1 Diabetes at the age of 16 and subsequent kidney and pancreas transplants impacted her and the mission and goals of Lyfebulb.
• The roles of Patient Ambassadors and Patient Entrepreneurs.
• Why Lyfebulb is a patient-centric organization.
• The upcoming Lyfebulb-Helsinn Innovation Challenge.
• The future of Lyfebulb.

Apply For the Lyfebulb-Helsinn Innovation Challenge - https://lyfebulb.com/innovation-award/helsinn-2019/

Connect With Lyfebulb

Visit their website - https://lyfebulb.com/

Lyfebulb on Instagram - https://instagram.com/lyfebulb

Lyfebulb on Twitter - https://twitter.com/lyfebulb 

Lyfebulb on Facebook - https://www.facebook.com/Lyfebulb

Lyfebulb on YouTube - https://www.youtube.com/user/Lyfebulb

WE Have Cancer Links

Subscribe to the show:

Follow WE Have Cancer on Social Media

Know someone touched by cancer who has an inspiring story?